Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Sales | 37 | 869 | 508 | 0 | 0 |
| Gross Profit | 37 | 869 | 508 | N/A | N/A |
| Operating Expenses | 102,058 | 77,428 | 29,963 | 13,359 | 0 |
| Operating Income | -102,021 | -76,559 | -29,455 | -13,359 | N/A |
| Interest Expense | 861 | 0 | 0 | 0 | 0 |
| Other Income | 196 | -25 | 493 | 8 | 0 |
| Pre-tax Income | -102,686 | -76,584 | -28,962 | -13,351 | 0 |
| Income Tax | 444 | 472 | 444 | 113 | N/A |
| Net Income Continuous | -103,130 | -77,056 | -29,406 | -13,464 | N/A |
| Net Income | $-103,130 | $-77,056 | $-29,406 | $-13,464 | $N/A |
| EPS Basic Total Ops | -106.45 | -132.23 | -2,561.32 | -8,528.79 | N/A |
| EPS Basic Continuous Ops | -106.50 | -132.27 | -2,561.26 | -8,528.78 | N/A |
| EPS Diluted Total Ops | -106.45 | -132.23 | -2,561.32 | -8,528.79 | N/A |
| EPS Diluted Continuous Ops | -106.50 | -132.27 | -2,561.26 | -8,528.78 | N/A |
| EPS Diluted Before Non-Recurring Items | -106.45 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-101,507 | $-76,063 | $-29,390 | $-13,359 | $N/A |